VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $159 | -31.8% | 14,400 | 0.0% | 0.01% | -27.3% |
Q2 2023 | $233 | -2.9% | 14,400 | 0.0% | 0.01% | -8.3% |
Q1 2023 | $240 | +72.7% | 14,400 | -2.7% | 0.01% | +50.0% |
Q4 2022 | $139 | -99.7% | 14,800 | 0.0% | 0.01% | +300.0% |
Q3 2022 | $40,000 | -7.0% | 14,800 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $43,000 | -2.3% | 14,800 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $44,000 | -35.3% | 14,800 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $68,000 | -34.6% | 14,800 | -10.3% | 0.00% | -40.0% |
Q3 2021 | $104,000 | 0.0% | 16,500 | 0.0% | 0.01% | -16.7% |
Q1 2021 | $104,000 | -2.8% | 16,500 | -13.2% | 0.01% | -33.3% |
Q4 2020 | $107,000 | -14.4% | 19,000 | -11.6% | 0.01% | -25.0% |
Q3 2020 | $125,000 | -8.8% | 21,500 | +13.2% | 0.01% | -7.7% |
Q2 2020 | $137,000 | +53.9% | 19,000 | 0.0% | 0.01% | +18.2% |
Q1 2020 | $89,000 | -42.2% | 19,000 | -1.1% | 0.01% | -21.4% |
Q4 2019 | $154,000 | +16.7% | 19,207 | 0.0% | 0.01% | +7.7% |
Q3 2019 | $132,000 | +36.1% | 19,207 | +64.1% | 0.01% | +30.0% |
Q2 2019 | $97,000 | – | 11,707 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |